Why We Sold Walmart-It’s Not Why You Think

Introduction Walmart’s stock price took a bath early last week, and there are a lot of opinions regarding where the stock price now sits.  The catalyst was their 4th quarter and fiscal year-end 2018 annual report (note: Walmart has a January 31 fiscal year end).  The following headlines courtesy of “Google Finance” illustrate the variance Read more about Why We Sold Walmart-It’s Not Why You Think[…]

Peter Lynch Taught Me to Invest in Ultra Beauty Inc.

Introduction In his best-selling book “One up on Wall Street” Peter Lynch included this subtitle on his cover: “How to use what you already know to make money in the stock market.”  And later in the book he talks about “the power of common knowledge.”  Stating it over simplistically, Peter Lynch often talked about getting Read more about Peter Lynch Taught Me to Invest in Ultra Beauty Inc.[…]

Are These The 6 Best Stocks In The Dow Jones Industrial Average? – Part 3 Of 5

Introduction In Part 1 and Part 2  of this series I covered 12 of the 30 Dow Jones Industrial Average stocks that I considered the most expensive of the index.  With this part 3 I will be looking at 6 additional Dow stocks that for the most part I would consider fully valued to only Read more about Are These The 6 Best Stocks In The Dow Jones Industrial Average? – Part 3 Of 5[…]

6 More Expensive Stocks in the Dow Jones Industrial Average: Part 2 of 5

Introduction In part 1 of this five-part series, I covered what I considered the 6 most expensive stocks in the Dow Jones Industrial Average Index of 30 stocks.  With this part 2, I’m going to cover 6 additional Dow stocks that I consider overvalued currently.  So far, these two articles represent approximately 40% of the Read more about 6 More Expensive Stocks in the Dow Jones Industrial Average: Part 2 of 5[…]

My Visa Long is Getting Long in the Tooth

Introduction Over my lifetime I have invested in many different things.  In the process of doing that, I have learned that there are really only two types of investors.  As an investor, you are either active or passive.  Being active implies directly managing or being in control of your investment.  In contrast, as a passive Read more about My Visa Long is Getting Long in the Tooth[…]

Nvidia: Forecast Profits and/or Cash Flow Not Prices!

Introduction This will be the first in a series of articles where I will cover popular and/or high profile stocks.  The primary objective of this series will be to put a spotlight on the importance of forecasting future growth prior to making an investment decision.  The central idea is to determine whether or not a Read more about Nvidia: Forecast Profits and/or Cash Flow Not Prices![…]

The Active versus Passive Performance Debate Is Nonsensical

Introduction One of the most hotly contested debates in finance is the argument over which is better – active or passive investing.  Moreover, this debate has spurred numerous academic studies that claim to identify whether passive outperforms active investing or vice versa.  As a result, the current popular opinion suggests that passive outperforms active investing Read more about The Active versus Passive Performance Debate Is Nonsensical[…]

5 Fairly Valued MLPs: Is the Dilution Worth the Yield and How Do You Value Them?

Introduction The 5 MLPs covered in this article offer yields ranging from 5.7% to 10.7%.  Additionally, each of these MLPs appears reasonably valued given their high yields and prospects for growth.  However, two of these MLPs are currently in the process of merging. MLPs Simple and Complex at the Same Time I believe that MLPs Read more about 5 Fairly Valued MLPs: Is the Dilution Worth the Yield and How Do You Value Them?[…]

Pfizer Inc. Invest For Attractive Valuation and The 4% Dividend Yield

Investment Thesis Pfizer Inc (PFE) is one of the world’s largest pharmaceutical firms with sales exceeding $50 billion.  The company is currently attractively valued at a blended P/E ratio of 13.3, offering a current dividend yield of 4%.  Pfizer is awarded an S&P credit rating of AA and possesses a modest debt to capital ratio Read more about Pfizer Inc. Invest For Attractive Valuation and The 4% Dividend Yield[…]